Ultralente insulin and Rhabdomyolysis - a phase IV clinical study of FDA data

Summary:

Rhabdomyolysis is reported only by a few people who take Ultralente Insulin.

The phase IV clinical study analyzes which people take Ultralente insulin and have Rhabdomyolysis. It is created by eHealthMe based on reports of 101 people who have side effects while taking Ultralente insulin from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Oct, 03, 2022

101 people reported to have side effects when taking Ultralente insulin.
Among them, 3 people (2.97%) have Rhabdomyolysis.


What is Ultralente insulin?

Ultralente insulin has active ingredients of insulin zinc susp extended beef. eHealthMe is studying from 102 Ultralente insulin users for its effectiveness, alternative drugs and more.

What is Rhabdomyolysis?

Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down) is found to be associated with 2,286 drugs and 1,852 conditions by eHealthMe.

Number of Ultralente insulin and Rhabdomyolysis reports submitted per year:

Could Ultralente insulin cause Rhabdomyolysis?

Gender of people who have Rhabdomyolysis when taking Ultralente insulin*:

Click here to view

Age of people who have Rhabdomyolysis when taking Ultralente insulin *:

Click here to view

Common drugs people take besides Ultralente insulin *:

Click here to view

Common side effects people have besides Rhabdomyolysis *:

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take Ultralente insulin and have Rhabdomyolysis?

Check whether Rhabdomyolysis is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

How severe was Rhabdomyolysis and when was it recovered:

Expand to all the drugs that have ingredients of insulin zinc susp extended beef:

Alternative drugs to, pros and cons of Ultralente insulin:

Rhabdomyolysis treatments and more:

COVID vaccines that are related to Rhabdomyolysis:

Common drugs associated with Rhabdomyolysis:

All the drugs that are associated with Rhabdomyolysis:

Common conditions associated with Rhabdomyolysis:

All the conditions that are associated with Rhabdomyolysis:

How the study uses the data?

The study uses data from the FDA. It is based on insulin zinc susp extended beef (the active ingredients of Ultralente insulin) and Ultralente insulin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: